ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Article in Frontiers in Immunology (September 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy
Article in Bioengineering & Translational Medicine (August 2024)
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors
Article in Seminars in Immunopathology (July 2024)